302 related articles for article (PubMed ID: 33243118)
1. A Review on Rheumatoid Arthritis Interventions and Current Developments.
Khanna N; Kumar A; Pawar SV
Curr Drug Targets; 2021; 22(4):463-483. PubMed ID: 33243118
[TBL] [Abstract][Full Text] [Related]
2. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
Xu R; Wang Q
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
[TBL] [Abstract][Full Text] [Related]
3. The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery.
Machaj F; Rosik J; Szostak B; Pawlik A
Expert Opin Drug Discov; 2020 Jan; 15(1):85-99. PubMed ID: 31661990
[No Abstract] [Full Text] [Related]
4. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
Han Y; Huang S
J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
[TBL] [Abstract][Full Text] [Related]
5. Can pyroptosis be a new target in rheumatoid arthritis treatment?
Wu D; Li Y; Xu R
Front Immunol; 2023; 14():1155606. PubMed ID: 37426634
[TBL] [Abstract][Full Text] [Related]
6. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
7. Novel Nano Carriers for the Treatment of Progressive Auto Immune Disease Rheumatoid Arthritis.
Mishra R; Gupta S
Curr Pharm Des; 2021; 27(21):2468-2481. PubMed ID: 33087024
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic advances in rheumatoid arthritis.
Brown P; Pratt AG; Hyrich KL
BMJ; 2024 Jan; 384():e070856. PubMed ID: 38233032
[TBL] [Abstract][Full Text] [Related]
9. Update in rheumatoid arthritis therapy.
Kim-Howard XR; Staudt L; James JA
J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642
[TBL] [Abstract][Full Text] [Related]
10. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date.
Crotti C; Raimondo MG; Becciolini A; Biggioggero M; Favalli EG
Drug Des Devel Ther; 2017; 11():211-223. PubMed ID: 28144129
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canada.
Russell A; Haraoui B; Keystone E; Klinkhoff A
Clin Ther; 2001 Nov; 23(11):1824-38; discussion 1791. PubMed ID: 11768835
[TBL] [Abstract][Full Text] [Related]
12. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.
Huang J; Fu X; Chen X; Li Z; Huang Y; Liang C
Front Immunol; 2021; 12():686155. PubMed ID: 34305919
[TBL] [Abstract][Full Text] [Related]
13. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
14. Rationalized Insights on Causes of Rheumatoid Arthritis in the Elderly and Women: Special Emphasis on Treatment Strategies.
Srivastava S; Patel S; Singh D; Singh MR
Crit Rev Ther Drug Carrier Syst; 2017; 34(2):97-147. PubMed ID: 28605317
[TBL] [Abstract][Full Text] [Related]
15. Current Developments in Therapeutic Drug Targeting for the Management of Rheumatoid Arthritis: An Emerging Paradigm.
Pai DR; Venkatesh MP; Kumar TMP
Crit Rev Ther Drug Carrier Syst; 2019; 36(6):485-536. PubMed ID: 32421953
[TBL] [Abstract][Full Text] [Related]
16. Advances in Formulations of Microneedle System for Rheumatoid Arthritis Treatment.
Guo P; Huang C; Yang Q; Zhong G; Zhang J; Qiu M; Zeng R; Gou K; Zhang C; Qu Y
Int J Nanomedicine; 2023; 18():7759-7784. PubMed ID: 38144510
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
[TBL] [Abstract][Full Text] [Related]
19. New therapeutics in rheumatoid arthritis.
Savage C; St Clair EW
Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis.
Shen Q; Du Y
Int J Pharm; 2023 Mar; 635():122698. PubMed ID: 36754181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
